Follow
Artrya Limited (AYAUF) Q2 2026 Earnings Call February 1, 2026 7:01 PM EST
Company Participants
John Konstantopoulos – Co-Founder & CEO
Richard Jarvis – Chief Financial Officer
Conference Call Participants
David Allen – Hawkesbury Partners Pty Limited
Presentation
David Allen
Hawkesbury Partners Pty Limited
Welcome to the December 2025 quarterly results and outlook. My name is David Allen from Hawkesbury Partners, and I’ll be your host for the call today. The Artrya host for today’s call is John Konstantopoulos, CEO and Co-Founder. He’s also joined today by Bernie Ridgeway, Executive Chairman; and Richard Jarvis, Chief Financial Officer.
This call is also being recorded and participants are in a listen-only mode. There will be a question-and-answer session following the presentation and if you’d like to ask a question at that time, then please type it into the Zoom Q&A section. A recording of today’s call will also be on Artrya’s website shortly. I’ll now hand over the call to John Konstantopoulos, CEO of Artrya. Please go ahead.
John Konstantopoulos
Co-Founder & CEO
Thanks, David, and good morning, everybody. It’s great to be speaking with listeners again after what’s been a really very busy quarter for us. The momentum that began with our commercial launch at Tanner Health continue to build with our expanded customer base of Cone Northeast — in Cone Health at Northeast Georgia, as well as our Salix Coronary Plaque module, which is now live alongside our Salix Coronary Anatomy platform.
As we highlighted at the AGM last November, the December quarter was a key focus for us to put the right commercial and operational foundations in place so that we can expand and grow in 2026. So with that in mind, one of our key objectives was to successfully — which we successfully completed last quarter was to convert all 3 of our
GIPHY App Key not set. Please check settings